Pharmaceutical Investing Invion: Revolutionizing Photodynamic Therapy (PDT) for Cancer, Infectious Diseases
Pharmaceutical Investing Pfizer Invites Shareholders to Attend Virtual 2025 Annual Meeting of Shareholders on April 24
Pharmaceutical Investing European Commission Approves Pfizer's RSV Vaccine ABRYSVO® to Help Protect Adults Aged 18-59 Against RSV Lower Respiratory Tract Disease
Pharmaceutical Investing ViiV Healthcare Announces Reimbursement for APRETUDE for HIV-1 Pre-Exposure Prophylaxis under the Non-Insured Health Benefits Program
Pharmaceutical Investing Pfizer Invites Public to View and Listen to Webcast of April 29 Conference Call with Analysts
Pharmaceutical Investing BMO Expands Canadian Depositary Receipt Lineup with 10 New Listings from Europe and Japan
Juggernaut Announces Strategic Investment by Crescat Capital Funds for 28.95% Ownership - Dr. Quinton Hennigh Technical Advisor
